12:
Vitamin D 1alpha-hydroxylase (CYP1alpha) polymorphism in Graves' disease, Hashimoto's thyroiditis and type 1 diabetes mellitus.
Pani MA, Regulla K, Segni M, Krause M, Hofmann S, Hufner M, Herwig J, Pasquino AM, Usadel KH, Badenhoop K.
Eur J Endocrinol. 2002 Jun;146(6):777-81.
PMID: 12039697 [PubMed - indexed for MEDLINE]
Related Articles
15:
Hashimoto's thyroiditis and insulin-dependent diabetes mellitus: differences among individuals with and without abnormal thyroid function.
McCanlies E, O'Leary LA, Foley TP, Kramer MK, Burke JP, Libman A, Swan JS, Steenkiste AR, Mccarthy BJ, Trucco M, Dorman JS.
J Clin Endocrinol Metab. 1998 May;83(5):1548-51.
PMID: 9589653 [PubMed - indexed for MEDLINE]
Related Articles
16:
Defect of a subpopulation of natural killer immune cells in Graves' disease and Hashimoto's thyroiditis: normalizing effect of dehydroepiandrosterone sulfate.
Solerte SB, Precerutti S, Gazzaruso C, Locatelli E, Zamboni M, Schifino N, Bonacasa R, Rondanelli M, Taccani D, Ferrari E, Fioravanti M.
Eur J Endocrinol. 2005 May;152(5):703-12.
PMID: 15879355 [PubMed - indexed for MEDLINE]
Related Articles
19:
Identification of susceptibility loci for autoimmune thyroid disease to 5q31-q33 and Hashimoto's thyroiditis to 8q23-q24 by multipoint affected sib-pair linkage analysis in Japanese.
Sakai K, Shirasawa S, Ishikawa N, Ito K, Tamai H, Kuma K, Akamizu T, Tanimura M, Furugaki K, Yamamoto K, Sasazuki T.
Hum Mol Genet. 2001 Jun 15;10(13):1379-86.
PMID: 11440990 [PubMed - indexed for MEDLINE]
Related Articles